Royal Bank of Canada
ITRM

Royal Bank of Canada’s Iterum Therapeutics ITRM Stock Holding History

Royal Bank of Canada’s Portfolio ITRM Stock Details ITRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-5
Closed – – 7311
2025
Q2 		$0 Buy
+5
New +$5 ﹤0.01% 7174
2024
Q2 		– Sell
-100
Closed – – 7292
2024
Q1 		$0 Sell
100
-9,900
-99% -$16.1K ﹤0.01% 7284
2023
Q4 		$20K Buy
+10,000
New +$12.4K ﹤0.01% 6308
2022
Q1 		– Hold
0
– – – 7870
2021
Q4 		– Hold
0
– – – 7776
2021
Q2 		– Sell
-1,267
Closed -$27K – 7574
2021
Q1 		$27K Buy
+1,267
New +$30.2K ﹤0.01% 6249
2020
Q4 		– Sell
-67
Closed -$1K – 7171
2020
Q3 		$1K Buy
+67
New +$895 ﹤0.01% 6440
2020
Q2 		– Sell
-337
Closed -$14K – 6749
2020
Q1 		$14K Buy
337
+137
+69% +$5.76K ﹤0.01% 5700
2019
Q4 		$14K Hold
200
– – ﹤0.01% 6018
2019
Q3 		$17K Sell
200
-207
-51% -$20.2K ﹤0.01% 5565
2019
Q2 		$42K Hold
407
– – ﹤0.01% 5360
2019
Q1 		$48K Sell
407
-1,086
-73% -$99.6K ﹤0.01% 5180
2018
Q4 		$112K Buy
1,493
+440
+42% +$41.6K ﹤0.01% 4666
2018
Q3 		$105K Buy
1,053
+557
+112% +$72.8K ﹤0.01% 4828
2018
Q2 		$79K Buy
+496
New +$89.6K ﹤0.01% 4940

Other funds holding ITRM

Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return
AF
Apollon Financial Mount Pleasant, South Carolina $848M AUM 27.31% 1-Year Est. Return
OIA
OneDigital Investment Advisors Overland Park, Kansas $11.8B AUM 21.23% 1-Year Est. Return
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors Raleigh, North Carolina $65.5B AUM 24.25% 1-Year Est. Return
GWP
Gen-Wealth Partners Zeeland, Michigan $360M AUM 27.44% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
KF
Krilogy Financial St. Louis, Missouri $3.38B AUM 30.57% 1-Year Est. Return
SA
Sanctuary Advisors Indianapolis, Indiana $21.6B AUM 28.31% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

Royal Bank of Canada's ITRM Position: Q3 2025 in Review

Royal Bank of Canada sold out of Iterum Therapeutics (ITRM) in Q3 2025, closing a stake of 5 shares.

Royal Bank of Canada first reported a position in ITRM in Q2 2018 and held it in 13 quarters. The position peaked at $112K in Q4 2018. 24 funds tracked by Wall St. Rank hold ITRM as of Q3 2025.

  • Royal Bank of Canada reported no remaining Iterum Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Royal Bank of Canada sold 5 Iterum Therapeutics shares in Q3 2025.
  • Royal Bank of Canada first reported a position in Iterum Therapeutics in Q2 2018 and held it in 13 quarters.
  • Royal Bank of Canada's Iterum Therapeutics position peaked at $112K in Q4 2018.
  • 24 funds tracked by Wall St. Rank held Iterum Therapeutics as of Q3 2025.

Based on Royal Bank of Canada's 13F filing for Q3 2025, filed 14 Nov 2025.